Receptor Binding Domain Based HIV Vaccines
Joint Authors
Liu, Huan
Bi, Wenwen
Wang, Qian
Lu, Lu
Jiang, Shibo
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-01-15
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
This paper analyzes the main trend of the development of acquired immunodeficiency syndrome (AIDS) vaccines in recent years.
Designing an HIV-1 vaccine that provides robust protection from HIV-1 infection remains a challenge despite many years of effort.
Therefore, we describe the receptor binding domain of gp120 as a target for developing AIDS vaccines.
And we recommend some measures that could induce efficiently and produce cross-reactive neutralizing antibodies with high binding affinity.
Those measures may offer a new way of the research and development of the potent and broad AIDS vaccines.
American Psychological Association (APA)
Liu, Huan& Bi, Wenwen& Wang, Qian& Lu, Lu& Jiang, Shibo. 2015. Receptor Binding Domain Based HIV Vaccines. BioMed Research International،Vol. 2015, no. 2015, pp.1-9.
https://search.emarefa.net/detail/BIM-1056048
Modern Language Association (MLA)
Bi, Wenwen…[et al.]. Receptor Binding Domain Based HIV Vaccines. BioMed Research International No. 2015 (2015), pp.1-9.
https://search.emarefa.net/detail/BIM-1056048
American Medical Association (AMA)
Liu, Huan& Bi, Wenwen& Wang, Qian& Lu, Lu& Jiang, Shibo. Receptor Binding Domain Based HIV Vaccines. BioMed Research International. 2015. Vol. 2015, no. 2015, pp.1-9.
https://search.emarefa.net/detail/BIM-1056048
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1056048
